Project Profile
Share QR code

Protocol: GS-US-337-0102 A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5885Fixed-Dose Combination ± Ribavirin for 12 and 24 Weeks inTreatment-Naïve Subjects with Chronic Genotype 1 HCV Infec

Developed by The Clearinghouse for Applied Research
© 1999-2024, State of Florida
About
Discover
Connect
Disclaimer of Liability | Privacy Policy

Back to top

Keyword Search

Please enter valid search criteria.
Search
University

Browse by STEM

Biotechnology Computer Science Energy Engineering Environmental Sciences Information Science Life Sciences Mathematics Medical Sciences
Military Sciences Natural Sciences Physical Sciences Plant Sciences Science Space Sciences Technology Transportation